SR

Sam Rubenstein

Director, Global BioPharma Business Development at Pillar Biosciences

Sam Rubenstein has a strong background in the biomedical industry, with extensive experience in commercial and strategic leadership roles. Sam has worked for various companies, including Pillar Biosciences Incorporated, Labcorp, Eurofins, and Thermo Fisher Scientific.

At Pillar Biosciences Incorporated, Sam currently serves as the Director of Global BioPharma Business Development. In this role, they provide next-generation sequencing (NGS) solutions for oncology solid and liquid tumor precision, as well as consults with clinical and research organizations on companion diagnostic (CDx) development. Sam utilizes patented technology to improve and shorten workflow, enabling customers to achieve results in as little as 72 hours.

Before joining Pillar Biosciences Incorporated, Sam worked as the Executive Director of Oncology at Labcorp. Sam was responsible for leading the Southeast region's oncology and precision medicine portfolio. Sam'sgoal was to ensure that healthcare providers and their patients received the highest quality of care available in modern medicine. Sam also collaborated with Covance to accelerate new therapeutic development and bring innovative therapies and diagnostics to the market.

Prior to their role at Labcorp, Sam served as the Commercial Director at Eurofins from 2019 to 2020. In this position, they contributed to the company's commercial success.

Sam's earlier experience includes working at Thermo Fisher Scientific as the Global Commercial Director for Solutions and Clinical Ancillary Management. Sam led the commercial and solutions teams focused on delivering ancillary supplies for global clinical trials, with a focus on the Biopharma Services Division of Fisher Clinical Services. Sam demonstrated strategic leadership and global matrix management skills during their tenure.

Overall, Sam Rubenstein has a proven track record of driving commercial success, developing innovative solutions, and building partnerships within the biomedical industry.

Sam Rubenstein holds a Bachelor of Science degree in Biology/Biological Sciences, General from Indiana University Bloomington. No information is available regarding the start and end years of Sam's education at this institution.

Links

Previous companies

LabCorp logo

Timeline

  • Director, Global BioPharma Business Development

    March, 2023 - present